PALOMA-3 study

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

PALOMA-3 study

Dec 17, 2024, 16:18 | Insight

Update on U.S. Regulatory Review of Subcutaneous Amivantamab

Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has issued a…

Jul 1, 2024, 15:01 | Blog

Antonio Passaro: A significant milestone for the advancement and understanding of EGFR-mutated NSCLC

Antonio Passaro, shared a post on LinkedIn: "I am honored to have contributed, as investigator…

Jun 21, 2024, 10:50 | Blog

Out in JCO the groundbreaking results of the randomized phase 3 trial PALOMA-3 study

Antonio Passaro, Medical Oncologist at the European Institute of Oncology, shared on LinkedIn: "Out in…

All: 3 Posts: 1 - 100

'

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology

'

Richard Goldberg: Agenus Anticipates Interacting with FDA with New Data Coming at ESMO-GI 2025

'

USA vs Europe: Who Does Cancer Screening Better?

'

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

'

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023